|
| dbGaP Submitter Subject ID (ID2) | Coriell Sample ID | Consent | Control | Gender | Race | Age | Baseline Max AMD Severity | Final Max AMD Severity |
| AR2_1859 | ED148172 | General Research Use | No | Female | White | 77 | 9 - AREDS AMD Severity Scale Step 9 | 10 - Central GA |
| AR2_2262 | ED148849 | General Research Use | No | Female | White | 74 | 9 - AREDS AMD Severity Scale Step 8 | 10 - Central GA |
| AR2_2396 | ED149151 | General Research Use | No | Female | White | 67 | 9 - AREDS AMD Severity Scale Step 9 | 11b - Neovascular AMD with end-stage disease (e.g., definite disciform scar, or photocoagulation scar), or two or more of the following five characteristics of neovascular AMD: SSR detachment, PED, subretinal/sub-RPE hemorrhage, hard exudate, or fibrous tissue |
| AR2_3456 | ED148630 | General Research Use | No | Male | White | 72 | 9 - AREDS AMD Severity Scale Step 9 | 10 - Central GA |
| AR2_2145 | ED149508 | General Research Use | No | Male | White | 81 | 9 - AREDS AMD Severity Scale Step 6 | 11b - Neovascular AMD with end-stage disease (e.g., definite disciform scar, or photocoagulation scar), or two or more of the following five characteristics of neovascular AMD: SSR detachment, PED, subretinal/sub-RPE hemorrhage, hard exudate, or fibrous tissue |
| AR2_3693 | ED148499 | General Research Use | No | Female | White | 71 | 9 - AREDS AMD Severity Scale Step 9 | 10 - Central GA |
| AR2_3986 | ED149088 | General Research Use | No | Female | White | 77 | 9 - AREDS AMD Severity Scale Step 9 | 11b - Neovascular AMD with end-stage disease (e.g., definite disciform scar, or photocoagulation scar), or two or more of the following five characteristics of neovascular AMD: SSR detachment, PED, subretinal/sub-RPE hemorrhage, hard exudate, or fibrous tissue |
| AR2_0510 | ED148369 | General Research Use | No | Female | White | 76 | 9 - AREDS AMD Severity Scale Step 9 | 11b - Neovascular AMD with end-stage disease (e.g., definite disciform scar, or photocoagulation scar), or two or more of the following five characteristics of neovascular AMD: SSR detachment, PED, subretinal/sub-RPE hemorrhage, hard exudate, or fibrous tissue |
| AR2_0738 | ED149645 | General Research Use | No | Female | White | 67 | 9 - AREDS AMD Severity Scale Step 4 | 9 - AREDS AMD Severity Scale Step 9 |
| AR2_1308 | ED148648 | General Research Use | No | Female | Asian | 79 | 9 - AREDS AMD Severity Scale Step 9 | 9 - AREDS AMD Severity Scale Step 9 |
| AR2_1331 | ED148533 | General Research Use | No | Male | White | 80 | 9 - AREDS AMD Severity Scale Step 7 | 11b - Neovascular AMD with end-stage disease (e.g., definite disciform scar, or photocoagulation scar), or two or more of the following five characteristics of neovascular AMD: SSR detachment, PED, subretinal/sub-RPE hemorrhage, hard exudate, or fibrous tissue |
| AR2_2117 | ED149023 | General Research Use | No | Female | White | 72 | 9 - AREDS AMD Severity Scale Step 7 | 11b - Neovascular AMD with end-stage disease (e.g., definite disciform scar, or photocoagulation scar), or two or more of the following five characteristics of neovascular AMD: SSR detachment, PED, subretinal/sub-RPE hemorrhage, hard exudate, or fibrous tissue |
| AR2_2669 | ED148053 | General Research Use | No | Female | White | 76 | 9 - AREDS AMD Severity Scale Step 8 | 10 - Central GA |
| AR2_2149 | ED149970 | General Research Use | No | Female | White | 77 | 9 - AREDS AMD Severity Scale Step 9 | 11b - Neovascular AMD with end-stage disease (e.g., definite disciform scar, or photocoagulation scar), or two or more of the following five characteristics of neovascular AMD: SSR detachment, PED, subretinal/sub-RPE hemorrhage, hard exudate, or fibrous tissue |
| AR2_2324 | ED148407 | General Research Use | No | Female | White | 64 | 9 - AREDS AMD Severity Scale Step 6 | 10 - Central GA |
| AR2_0350 | ED148945 | General Research Use | No | Female | White | 77 | 9 - AREDS AMD Severity Scale Step 9 | 11b - Neovascular AMD with end-stage disease (e.g., definite disciform scar, or photocoagulation scar), or two or more of the following five characteristics of neovascular AMD: SSR detachment, PED, subretinal/sub-RPE hemorrhage, hard exudate, or fibrous tissue |
| AR2_1443 | ED148156 | General Research Use | No | Female | White | 79 | 9 - AREDS AMD Severity Scale Step 9 | 11b - Neovascular AMD with end-stage disease (e.g., definite disciform scar, or photocoagulation scar), or two or more of the following five characteristics of neovascular AMD: SSR detachment, PED, subretinal/sub-RPE hemorrhage, hard exudate, or fibrous tissue |
| AR2_1762 | ED149119 | General Research Use | No | Female | White | 74 | 9 - AREDS AMD Severity Scale Step 8 | 11b - Neovascular AMD with end-stage disease (e.g., definite disciform scar, or photocoagulation scar), or two or more of the following five characteristics of neovascular AMD: SSR detachment, PED, subretinal/sub-RPE hemorrhage, hard exudate, or fibrous tissue |
| AR2_2183 | ED149882 | General Research Use | No | Female | White | 79 | 9 - AREDS AMD Severity Scale Step 8 | 11b - Neovascular AMD with end-stage disease (e.g., definite disciform scar, or photocoagulation scar), or two or more of the following five characteristics of neovascular AMD: SSR detachment, PED, subretinal/sub-RPE hemorrhage, hard exudate, or fibrous tissue |
| AR2_3337 | ED148473 | Eye Disease Only | No | Male | White | 78 | 9 - AREDS AMD Severity Scale Step 9 | 10 - Central GA |